Search results
Man who received 1st pig kidney transplant has died. Why experts say animal organs could still 'turn...
Yahoo Life· 2 days agoHe suffered from end-stage heart disease and wasn’t eligible for a human heart transplant due to...
The first man to receive a kidney transplant from a genetically modified pig has died
NPR· 13 hours agoYou have people with different levels in terms of their health status. STEIN: Some think a carefully designed study would be a much better way to evaluate organs from genetically modified pigs ...
First human to receive transplanted pig kidney dies By Reuters
Investing.com· 13 hours ago"The Mass General transplant team is deeply saddened at the sudden passing of Mr. Rick Slayman," the...
More people need transplants than there are organ donors. Pigs might be a solution
CNN via Yahoo News· 6 days agoThe need for transplant organs is immense and growing. Some scientists think animal organs might be...
Diminishing the Organ Donation Wait List with Xenotransplantation
The National Law Review· 7 days agoIn just the US, more than 100,000 men, women, and children are waiting for an organ transplant....
1st person to receive a pig kidney transplant has died
Live Science via Yahoo News· 2 days agoThe patient also simultaneously received antibody-based treatments and immune-suppressing drugs to...
‘Diary of a Dying Girl’: A mother’s loss launches a global effort to fight antibiotic resistance
Roanoke Times· 3 days agoIn November 2017, days after her daughter Mallory Smith died from a drug-resistant infection at the...
Nykode Therapeutics - Quarterly report Q1 2024
Benzinga· 1 day agoOSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced its
Natera Reports 52 Percent Spike in Q1 Revenues, Raises Full-Year Guidance
GenomeWeb News· 5 days agoNatera reported after the close of the market on Thursday a 52 percent year-over-year spike in its first quarter revenues on increased testing volumes and improvements in average test selling ...
Biodexa Pharmaceuticals (LON:MTPH) Share Price Passes Above 50 Day Moving Average of $18.00
ETF DAILY NEWS· 1 day agoBiodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 18 ($0.23) and ...
